Research and Markets: Cardiac Arrest Global Clinical Trials Review, H1, 2013

Wed Mar 6, 2013 12:55pm EST

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130306:nBw066157a

DUBLIN--(Business Wire)--

Research and Markets

(http://www.researchandmarkets.com/research/nqtd87/cardiac_arrest) has announced
the addition of GlobalData's new report "Cardiac Arrest Global Clinical Trials
Review, H1, 2013" to their offering. 

Our clinical trial report, Cardiac Arrest Global Clinical Trials Review, H1,
2013" provides data on the Cardiac Arrest clinical trial scenario. This report
provides elemental information and data relating to the clinical trials on
Cardiac Arrest. It includes an overview of the trial numbers and their
recruitment status as per the site of trial conduction across the globe. The
databook offers a preliminary coverage of disease clinical trials by their
phase, trial status, prominence of the sponsors and also provides briefing
pertaining to the number of trials for the key drugs for treating Cardiac
Arrest. This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by Our team of
industry experts. 

Scope 

- Data on the number of clinical trials conducted in North America, South and
Central America, Europe, Middle-East and Africa and Asia-pacific and top five
national contributions in each, along with the clinical trial scenario in BRIC
nations 

- Clinical trial (complete and in progress) data by phase, trial status,
subjects recruited and sponsor type 

- Listings of discontinued trials (suspended, withdrawn and terminated) 

Reasons to buy 

- Understand the dynamics of a particular indication in a condensed manner 

- Abridged view of the performance of the trials in terms of their status,
recruitment, location, sponsor type and many more 

- Obtain discontinued trial listing for trials across the globe 

- Espy the commercial landscape of the major Universities / Institutes /
Hospitals or Companies

Key Topics Covered:

* Introduction 
* Cardiac Arrest 
* Report Guidance 
* Clinical Trials by Region 
* Clinical Trials by Country 
* Top Five Countries Contributing to Clinical Trials in Asia-Pacific 
* Top Five Countries Contributing to Clinical Trials in Europe 
* Top Countries Contributing to Clinical Trials in North America 
* Top Countries Contributing to Clinical Trials in Middle East and Africa 
* Top Countries Contributing to Clinical Trials in Central and South America 
* Clinical Trials by BRIC Nations 
* Clinical Trials by G7 Nations 
* Clinical Trials in G7 Nations by Trial Status 
* Clinical Trials by E7 Nations 
* Clinical Trials in E7 Nations by Trial Status 
* Clinical Trials by Phase 
* In Progress Trials by Phase 
* Clinical Trials by Trial Status 
* Unaccomplished Trials of Cardiac Arrest 
* Subjects Recruited Over a Period of Time 
* Prominent Sponsors 
* Top Companies Participating in Cardiac Arrest Therapeutics Clinical Trials 
* Prominent Drug Comparison 
* Clinical Trial Profiles 
* Five Key Clinical Profiles 
* Appendix 
* Abbreviations 
* Definitions 
* Research Methodology 
* Secondary Research

For more information visit
http://www.researchandmarkets.com/research/nqtd87/cardiac_arrest

Source: GlobalData

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular

Copyright Business Wire 2013